Skip to Main Content
Skip Nav Destination

Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease

Hematology Am Soc Hematol Educ Program (2022) 2022 (1): 266–271.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal